Strata Critical Medical (SRTA) Change in Cash (2019 - 2026)

Strata Critical Medical has disclosed Change in Cash across 8 years of filings, most recently posting $27.8 million for Q1 2026.

• In Q1 2026, Change in Cash rose 73.03% year-over-year to $27.8 million; the TTM figure through Mar 2026 stood at $23.3 million (up 1082.25% YoY), while the FY2025 annual figure was $11.6 million, up 223.59% from the prior year.
• Change in Cash rose to $27.8 million in Q1 2026, from $8.2 million in the prior quarter.
• Over the last five years, Change in Cash for SRTA reached as high as $185.0 million in Q2 2022 and fell as low as -$37.3 million in Q3 2025.
• The 5-year median for Change in Cash is -$604000.0 (2023), against an average of $13.4 million.
• The widest YoY moves for Change in Cash: up 1596.52% in 2024, down 521.98% in 2024.
• A 5-year view of Change in Cash shows it stood at $185.0 million in 2022, then slumped by 105.0% to -$9.3 million in 2023, then soared by 80.99% to -$1.8 million in 2024, then surged by 567.08% to $8.2 million in 2025, then jumped by 237.82% to $27.8 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $27.8 million, $8.2 million, and -$37.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.